What's in BeOne Medicines's pipeline?

BeOne Medicines has 22 drugs in our index: 0 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 19 in Phase 1.

Which companies overlap with BeOne Medicines's portfolio?

Top competitors by shared drug class: Jiangsu HengRui Medicine Co., Ltd., ATGC Co., Ltd., Asahi Kasei Pharma Corporation, Ahn-Gook Pharmaceuticals Co.,Ltd, Akeso.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/beone-medicines.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-06-09 · How we verify

BeOne Medicines — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BeOne Medicines pipeline: 0 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 3 Phase 3 0 Phase 2 19 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Subcutaneous Tislelizumab	Subcutaneous Tislelizumab	phase 3	PD-1 inhibitor	PD-1	Oncology
BGB-16673	BGB-16673	phase 3	Selective Estrogen Receptor Degrader (SERD)	Estrogen Receptor (ER)	Oncology
Intravenous Tislelizumab	Intravenous Tislelizumab	phase 3	PD-1 inhibitor	PD-1	Oncology

Therapeutic area mix

Oncology · 3

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Jiangsu HengRui Medicine Co., Ltd. · 2 shared drug classes
ATGC Co., Ltd. · 1 shared drug class
Asahi Kasei Pharma Corporation · 1 shared drug class
Ahn-Gook Pharmaceuticals Co.,Ltd · 1 shared drug class
Akeso · 1 shared drug class
Amgen · 1 shared drug class
Addpharma Inc. · 1 shared drug class
ASLAN Pharmaceuticals · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for BeOne Medicines:

Cite this brief

Drug Landscape (2026). BeOne Medicines — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/beone-medicines. Accessed 2026-06-09.